发明名称 |
Quantification of human mitochondrial DNA using synthesized DNA standards |
摘要 |
A real-time quantitative PCR assay that utilizes a duplex, synthetic DNA standard to ensure optimal quality assurance and quality control. One embodiment of the invention facilitates amplification of mtDNA by focusing on a 105-base pair target sequence that is minimally homologous to non-human mtDNA. The present invention can also be used to identify the presence of PCR inhibitors and thus indicate the need for sample repurification. |
申请公布号 |
US9080205(B2) |
申请公布日期 |
2015.07.14 |
申请号 |
US201213436277 |
申请日期 |
2012.03.30 |
申请人 |
The United States of America as represented by the Federal Bureau of Investigation, Department of Justice |
发明人 |
Kavlick Mark F.;Budowle Bruce |
分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
代理机构 |
|
代理人 |
Vidovich Kristin K. |
主权项 |
1. A process for quantifying human mitochondrial DNA, said process comprising:
amplifying a region of human mitochondrial DNA by contacting a biological sample containing human mitochondrial DNA with an oligonucleotide primer pair having a nucleotide sequence complementary to a target sequence located within the NADH dehydrogenase subunit 5 gene of said mitochondrial DNA, under conditions and for a time sufficient to allow hybridization of said primer pair to the mitochondrial DNA; detecting amplification following hybridization of the primer pair to the mitochondrial DNA; and quantifying the detected amplified product using a synthetic DNA standard comprising a signature nucleotide sequence, wherein the signature nucleotide sequence comprises nucleotide substitutions, which, if translated, would result in the introduction of a stop codon and an amino acid substitution in the target sequence. |
地址 |
Washington DC US |